{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:00:26Z","timestamp":1787763626876,"version":"build-2784847793"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T00:00:00Z","timestamp":1635811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T00:00:00Z","timestamp":1635811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012681","name":"Universit\u00e4tsklinikum K\u00f6ln","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012681","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Geriatr Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The Task Force for the diagnosis and management of atrial fibrillation (AF) of the European Society of Cardiology (ESC) published in 2020 the updated <jats:italic>Guidelines for the Diagnosis and Management of Atrial Fibrillation with the contribution of the European Heart Rhythm Association (EHRA) of the ESC and the European Association for Cardiothoracic Surgery (EACTS)<\/jats:italic>.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods and results<\/jats:title>\n                <jats:p>In this narrative viewpoint, we approach AF from the perspective of aging medicine and try to provide the readers with information usually neglected in clinical routine, mainly due to the fact that while the large majority of AF patients in real life are older, frail and cognitively impaired, these are mostly excluded from clinical trials, and physicians\u2019 attitudes often prevail over standardized algorithms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>On the basis of existing evidence, (1) opportunistic AF screening by pulse palpation or ECG rhythm strip is cost-effective, and (2) whereas advanced chronological age by itself is not a contraindication to AF treatment, a Comprehensive Geriatric Assessment (CGA) including frailty, cognitive impairment, falls and bleeding risk may assist in clinical decision making to provide the best individualized treatment.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s41999-021-00537-w","type":"journal-article","created":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T17:23:17Z","timestamp":1635873797000},"page":"5-18","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Atrial fibrillation: a geriatric perspective on the 2020 ESC guidelines"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8881-904X","authenticated-orcid":false,"given":"M. Cristina","family":"Polidori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulistan","family":"Bahat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Sophie","family":"Boureau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serdar","family":"Ozkok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Pfister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Pilotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Veronese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2945-0243","authenticated-orcid":false,"given":"Mario","family":"Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the Special Interest Group \u201cCardiovascular Diseases\u201d of the EuGMS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,2]]},"reference":[{"key":"537_CR1","doi-asserted-by":"crossref","unstructured":"Hindricks G, Potpara T, Dagres N et al. (2020) ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur Heart J 42:373498. https:\/\/www.escardio.org\/Guidelines\/Clinical-Practice-Guidelines\/Guidelines-development\/Writing-ESCGuidelines","DOI":"10.1093\/eurheartj\/ehaa945"},{"key":"537_CR2","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D et al (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37:2893\u20132962. https:\/\/doi.org\/10.1093\/eurheartj\/ehw210","journal-title":"Eur Heart J"},{"issue":"11","key":"537_CR3","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1001\/jama.1994.03510350050036","volume":"271","author":"EJ Benjamin","year":"1994","unstructured":"Benjamin EJ, Levy D, Vaziri SM et al (1994) Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham heart study. JAMA 271(11):840\u2013844","journal-title":"JAMA"},{"key":"537_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2019.00175","author":"Z Zathar","year":"2019","unstructured":"Zathar Z, Karunatilleke A, Fawzy AM et al (2019) Atrial fibrillation in older people: concepts and controversies. Front Med. https:\/\/doi.org\/10.3389\/fmed.2019.00175","journal-title":"Front Med"},{"issue":"35","key":"537_CR5","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1093\/eurheartj\/eht280","volume":"34","author":"BP Krijthe","year":"2013","unstructured":"Krijthe BP, Kunst A, Benjamin EJ et al (2013) Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J 34(35):2746\u20132751. https:\/\/doi.org\/10.1093\/eurheartj\/eht280","journal-title":"Eur Heart J"},{"key":"537_CR6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.115.003525.PMID:27052031;PMCID:PMC4826757","volume":"9","author":"JW Magnani","year":"2016","unstructured":"Magnani JW, Wang N, Benjamin EJ et al (2016) Atrial fibrillation and declining physical performance in older adults: the health, aging, and body composition study. Circ Arrhythm Electrophysiol 9:e003525. https:\/\/doi.org\/10.1161\/CIRCEP.115.003525.PMID:27052031;PMCID:PMC4826757","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"537_CR7","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1093\/ageing\/afy180","volume":"48","author":"C Wilkinson","year":"2019","unstructured":"Wilkinson C, Todd O, Clegg A et al (2019) Management of atrial fibrillation for older people with frailty: a systematic review and meta-analysis. Age Ageing 48:196\u2013203. https:\/\/doi.org\/10.1093\/ageing\/afy180","journal-title":"Age Ageing"},{"key":"537_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.15420\/ecr.2016:13:2","volume":"11","author":"A Alonso","year":"2016","unstructured":"Alonso A, Arenas-de-Larriva AP (2016) Atrial fibrillation, cognitive decline and dementia. Eur Cardiol. 11:49\u201353. https:\/\/doi.org\/10.15420\/ecr.2016:13:2","journal-title":"Eur Cardiol."},{"key":"537_CR9","doi-asserted-by":"crossref","unstructured":"Polidori MC (2021) Physiology of aging as a basis of complexity in aging medicine and geriatrics. In: Gu D, Dupre M (Eds) Ageing Medicine and Geriatrics. Polidori MC Section Ed. Encyclopedia of Gerontology and Population Aging. Springer","DOI":"10.1007\/978-3-030-22009-9_548"},{"issue":"3","key":"537_CR10","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.archger.2018.12.013","volume":"81","author":"D Caldeira","year":"2019","unstructured":"Caldeira D, Nunes-Ferreira A, Rodrigues R et al (2019) Non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation: a systematic review with meta-analysis and trial sequential analysis. Arch Gerontol Geriatr 81(3):209\u2013214. https:\/\/doi.org\/10.1016\/j.archger.2018.12.013","journal-title":"Arch Gerontol Geriatr"},{"key":"537_CR11","unstructured":"ICH E7 Studies in support of special populations: geriatrics | European Medicines Agency. https:\/\/www.ema.europa.eu\/en\/ich-e7-studies-support-special-populations-geriatrics. Accessed 16 Jan 2021"},{"issue":"3","key":"537_CR12","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s11239-018-1698-y","volume":"46","author":"AB Hughey","year":"2018","unstructured":"Hughey AB, Gu X, Haymart B et al (2018) Warfarin for prevention of thromboembolism in atrial fibrillation: comparison of patient characteristics and outcomes of the \u2018Real-World\u2019 Michigan Anticoagulation Quality Improvement Initiative (MAQI2) registry to the RE-LY, ROCKET-AF, and ARISTOTLE trials. J Thromb Thrombolysis 46(3):316\u2013324","journal-title":"J Thromb Thrombolysis"},{"issue":"3","key":"537_CR13","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jacep.2016.04.013","volume":"2","author":"L Bibas","year":"2016","unstructured":"Bibas L, Levi M, Touchette J (2016) Implications of frailty in elderly patients with electrophysiological conditions. JACC Clin Electrophysiol 2(3):288\u2013294. https:\/\/doi.org\/10.1016\/j.jacep.2016.04.013","journal-title":"JACC Clin Electrophysiol"},{"issue":"5","key":"537_CR14","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s40520-020-01516-0","volume":"32","author":"AJ Cruz-Jentoft","year":"2020","unstructured":"Cruz-Jentoft AJ, Daragjati J, Fratiglioni L et al (2020) Using the Multidimensional Prognostic Index (MPI) to improve cost-effectiveness of interventions in multimorbid frail older persons: results and final recommendations from the MPI_AGE European Project. Aging Clin Exp Res 32(5):861\u2013868. https:\/\/doi.org\/10.1007\/s40520-020-01516-0","journal-title":"Aging Clin Exp Res"},{"key":"537_CR15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/europace\/euz344","volume":"22","author":"TS Potpara","year":"2020","unstructured":"Potpara TS, Mujovic N, Lip GYH (2020) Challenges in stroke prevention among very elderly patients with atrial fibrillation: discerning facts from prejudices. Europace 22:173\u2013176","journal-title":"Europace"},{"key":"537_CR16","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.jacc.2010.05.028","volume":"56","author":"R Marinigh","year":"2010","unstructured":"Marinigh R, Lip GYH, Fiotti N et al (2010) Age as a risk factor for stroke in atrial fibrillation patients. J Am Coll Cardiol 56:827\u2013837","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"537_CR17","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.amjmed.2014.11.026","volume":"128","author":"G Boriani","year":"2015","unstructured":"Boriani G, Laroche C, Diemberger I et al (2015) Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry. Am J Med 128(5):509\u201318.e2","journal-title":"Am J Med"},{"issue":"4","key":"537_CR18","doi-asserted-by":"publisher","first-page":"e0195088","DOI":"10.1371\/journal.pone.0195088","volume":"13","author":"MP Turakhia","year":"2018","unstructured":"Turakhia MP, Shafrin J, Bognar K et al (2018) Estimated prevalence of undiagnosed atrial fibrillation in the United States. PLoS ONE 13(4):e0195088","journal-title":"PLoS ONE"},{"issue":"2","key":"537_CR19","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1160\/TH4-04-0383","volume":"112","author":"C Martinez","year":"2014","unstructured":"Martinez C, Katholing A, Freedman SB (2014) Adverse prognosis of incidentally detected ambulatory atrial fibrillation. A cohort study. Thromb Haemost 112(2):276\u2013286","journal-title":"Thromb Haemost"},{"key":"537_CR20","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1136\/bmj.39280.660567.55","volume":"335","author":"DA Fitzmaurice","year":"2007","unstructured":"Fitzmaurice DA, Hobbs FDR, Jowett S et al (2007) Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial. Br Med J (Clin Res Ed) 335:383","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"7","key":"537_CR21","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.amjcard.2014.07.016","volume":"114","author":"J Wiesel","year":"2014","unstructured":"Wiesel J, Arbesfeld B, Schechter D (2014) Comparison of the Microlife blood pressure monitor with the Omron blood pressure monitor for detecting atrial fibrillation. Am J Cardiol 114(7):1046\u20131048","journal-title":"Am J Cardiol"},{"issue":"1","key":"537_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/jce.12842","volume":"27","author":"DD McManus","year":"2016","unstructured":"McManus DD, Chong JW, Soni A et al (2016) PULSE-SMART: pulse-based arrhythmia discrimination using a novel smartphone application. J Cardiovasc Electrophysiol 27(1):51\u201357","journal-title":"J Cardiovasc Electrophysiol"},{"key":"537_CR23","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1160\/TH14-03-0231","volume":"111","author":"N Lowres","year":"2014","unstructured":"Lowres N, Neubeck L, Salkeld G et al (2014) Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies: the SEARCH-AF study. Thromb Haemost 111:1167\u20131176","journal-title":"Thromb Haemost"},{"key":"537_CR24","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1093\/europace\/euu057","volume":"16","author":"RG Tieleman","year":"2014","unstructured":"Tieleman RG, Plantinga Y, Rinkes D et al (2014) Validation and clinical use of a novel diagnostic device for screening of atrial fibrillation. Europace 16:1291\u20131295","journal-title":"Europace"},{"key":"537_CR25","doi-asserted-by":"publisher","first-page":"e210038","DOI":"10.1001\/jamacardio.2021.0038","volume":"24","author":"DJ Gladstone","year":"2021","unstructured":"Gladstone DJ, Wachter R, Schmalstieg-Bahr K, SCREEN-AF Investigators and Coordinators et al (2021) Screening for atrial fibrillation in the older population: a randomized clinical trial. JAMA Cardiol. 24:e210038. https:\/\/doi.org\/10.1001\/jamacardio.2021.0038","journal-title":"JAMA Cardiol."},{"key":"537_CR26","doi-asserted-by":"publisher","first-page":"e00400","DOI":"10.1161\/JAHA.116.004000","volume":"5","author":"B Freedman","year":"2016","unstructured":"Freedman B (2016) Screening for atrial fibrillation using a smartphone: is there an app for that? J Am Heart Assoc 5:e00400","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"537_CR27","doi-asserted-by":"publisher","first-page":"e0213198","DOI":"10.1371\/journal.pone.0213198","volume":"14","author":"P Petryszyn","year":"2019","unstructured":"Petryszyn P, Niewinski P, Staniak A et al (2019) Effectiveness of screening for atrial fibrillation and its determinants. A meta-analysis. PLoS ONE 14(3):e0213198","journal-title":"PLoS ONE"},{"issue":"10","key":"537_CR28","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1093\/europace\/eux177","volume":"19","author":"GH Mairesse","year":"2017","unstructured":"Mairesse GH, Moran P, Van Gelder IC, ESC Scientific Document Group et al (2017) Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulaci\u00f3n Card\u00edaca y Electrofisiolog\u00eda (SOLAECE). Europace 19(10):1589\u20131623","journal-title":"Europace"},{"issue":"19","key":"537_CR29","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1161\/CIRCULATIONAHA.116.026693","volume":"135","author":"B Freedman","year":"2017","unstructured":"Freedman B, Camm J, Calkins H, AF-Screen Collaborators et al (2017) AF-screen collaborators screening for atrial fibrillation: a report of the AF-SCREEN International Collaboration. Circulation 135(19):1851\u20131867","journal-title":"Circulation"},{"issue":"3","key":"537_CR30","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/02813432.2017.1358858","volume":"35","author":"J Jaakkola","year":"2017","unstructured":"Jaakkola J, Vasankari T, Virtanen R et al (2017) Reliability of pulse palpation in the detection of atrial fibrillation in an elderly population. Scand J Prim Health Care 35(3):293\u2013298","journal-title":"Scand J Prim Health Care"},{"issue":"2 suppl","key":"537_CR31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/2047487316670255","volume":"23","author":"J Orchard","year":"2016","unstructured":"Orchard J, Lowres N, Freedman SB et al (2016) Screening for atrial fibrillation during influenza vaccinations by primary care nurses using a smartphone electrocardiograph (iECG): a feasibility study. Eur J Prev Cardiol 23(2 suppl):13\u201320","journal-title":"Eur J Prev Cardiol"},{"issue":"12","key":"537_CR32","first-page":"1779","volume":"18","author":"M Proietti","year":"2016","unstructured":"Proietti M, Mairesse GH, Goethals P, Belgian Heart Rhythm Week Investigators et al (2016) A population screening programme for atrial fibrillation: a report from the Belgian Heart Rhythm Week screening programme. Europace 18(12):1779\u20131786","journal-title":"Europace"},{"issue":"6","key":"537_CR33","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1017\/S1463423617000494","volume":"18","author":"S Peckham","year":"2017","unstructured":"Peckham S, Hann A, Kendall S et al (2017) Health promotion and disease prevention in general practice and primary care: a scoping study. Prim Health Care Res Dev 18(6):529\u2013540","journal-title":"Prim Health Care Res Dev"},{"key":"537_CR34","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ejim.2019.10.026","volume":"71","author":"M Bo","year":"2020","unstructured":"Bo M, Marchionni N (2020) Practical use of direct oral anticoagulants (DOACs) in the older person with atrial fibrillation. Eur J Intern Med 71:32\u201338. https:\/\/doi.org\/10.1016\/j.ejim.2019.10.026","journal-title":"Eur J Intern Med"},{"issue":"11","key":"537_CR35","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1093\/europace\/eux288","volume":"19","author":"S Fumagalli","year":"2017","unstructured":"Fumagalli S, Potpara TS, Bjerregaard Larsen T et al (2017) Frailty syndrome: an emerging clinical problem in the everyday management of clinical arrhythmias. The results of the European Heart Rhythm Association survey. Europace 19(11):1896\u20131902. https:\/\/doi.org\/10.1093\/europace\/eux288","journal-title":"Europace"},{"key":"537_CR36","doi-asserted-by":"publisher","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","volume":"56","author":"LP Fried","year":"2001","unstructured":"Fried LP, Tangen CM, Walston J, Cardiovascular Health Study Collaborative Research Group et al (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56:M146\u2013M156","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"537_CR37","doi-asserted-by":"crossref","unstructured":"Bahat G, llhan B, Tufan A et al (2020) Success of simpler modified frailty scale to predict mortality among nursing home residents. J Nutr Health Ageing","DOI":"10.1007\/s12603-021-1613-7"},{"issue":"9","key":"537_CR38","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1056\/NEJM199503023320902","volume":"332","author":"JM Guralnik","year":"1995","unstructured":"Guralnik JM, Ferrucci L, Simonsick EM et al (1995) Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med 332(9):556\u2013561. https:\/\/doi.org\/10.1056\/NEJM199503023320902","journal-title":"N Engl J Med"},{"issue":"11","key":"537_CR39","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1111\/j.1532-5415.2007.01413.x","volume":"55","author":"SE Hardy","year":"2007","unstructured":"Hardy SE, Perera S, Roumani YF et al (2007) Improvement in usual gait speed predicts better survival in older adults. J Am Geriatr Soc 55(11):1727\u20131734. https:\/\/doi.org\/10.1111\/j.1532-5415.2007.01413.x","journal-title":"J Am Geriatr Soc"},{"key":"537_CR40","doi-asserted-by":"publisher","first-page":"433","DOI":"10.2147\/CIA.S45300","volume":"9","author":"X Chen","year":"2014","unstructured":"Chen X, Leng S, Mao G (2014) Frailty syndrome: an overview. Clin Interv Aging 9:433\u2013441. https:\/\/doi.org\/10.2147\/CIA.S45300","journal-title":"Clin Interv Aging"},{"key":"537_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2018.04.023","volume":"56","author":"U Junius-Walker","year":"2018","unstructured":"Junius-Walker U, Onder G, Soleymani D et al (2018) The essence of frailty: a systematic review and qualitative synthesis on frailty concepts and definitions. Eur J Intern Med 56:3\u201310. https:\/\/doi.org\/10.1016\/j.ejim.2018.04.023","journal-title":"Eur J Intern Med"},{"issue":"6","key":"537_CR42","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.jamda.2013.03.022","volume":"14","author":"JE Morley","year":"2013","unstructured":"Morley JE, Vellas B, van Kan AG et al (2013) Frailty consensus: a call to action. J Am Med Dir Assoc 14(6):392\u2013397. https:\/\/doi.org\/10.1016\/j.jamda.2013.03.022","journal-title":"J Am Med Dir Assoc"},{"issue":"4","key":"537_CR43","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s12603-020-1543-9","volume":"25","author":"G Bahat","year":"2021","unstructured":"Bahat G, Ozkok S, Kilic C et al (2021) SARC-F questionnaire detects frailty in older adults. J Nutr Health Aging 25(4):448\u2013453. https:\/\/doi.org\/10.1007\/s12603-020-1543-9","journal-title":"J Nutr Health Aging"},{"issue":"Supp 1","key":"537_CR44","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1017\/S1041610202008177","volume":"13","author":"K Rockwood","year":"2001","unstructured":"Rockwood K, Wolfson C, McDowell I (2001) The Canadian Study of Health and Aging: organizational lessons from a national, multicenter, epidemiologic study. Int Psychogeriatr 13(Supp 1):233\u2013237. https:\/\/doi.org\/10.1017\/S1041610202008177","journal-title":"Int Psychogeriatr"},{"issue":"5","key":"537_CR45","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1503\/cmaj.050051","volume":"173","author":"K Rockwood","year":"2005","unstructured":"Rockwood K (2005) A global clinical measure of fitness and frailty in elderly people. Can Med Assoc J 173(5):489\u2013495. https:\/\/doi.org\/10.1503\/cmaj.050051","journal-title":"Can Med Assoc J"},{"issue":"1","key":"537_CR46","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1161\/CIRCHEARTFAILURE.109.865022","volume":"3","author":"A Pilotto","year":"2010","unstructured":"Pilotto A, Addante F, Franceschi M et al (2010) Multidimensional Prognostic Index based on a comprehensive geriatric assessment predicts short-term mortality in older patients with heart failure. Circ Heart Fail 3(1):14\u201320. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.109.865022","journal-title":"Circ Heart Fail"},{"issue":"1","key":"537_CR47","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1089\/rej.2007.0569","volume":"11","author":"A Pilotto","year":"2008","unstructured":"Pilotto A, Ferrucci L, Franceschi M et al (2008) Development and validation of a multidimensional prognostic index for one-year mortality from comprehensive geriatric assessment in hospitalized older patients. Rejuvenation Res 11(1):151\u2013161. https:\/\/doi.org\/10.1089\/rej.2007.0569","journal-title":"Rejuvenation Res"},{"key":"537_CR48","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.13989","volume":"6","author":"L Pickert","year":"2021","unstructured":"Pickert L, Meyer AM, Becker I et al (2021) Role of a multidimensional prognosis in-hospital monitoring for older patients with prolonged stay. Int J Clin Pract 6:e13989. https:\/\/doi.org\/10.1111\/ijcp.13989","journal-title":"Int J Clin Pract"},{"issue":"10","key":"537_CR49","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1093\/europace\/euz234","volume":"21","author":"M Kloosterman","year":"2019","unstructured":"Kloosterman M, Crijns HJGM, Van Gelder IC (2019) Rising prevalence of atrial fibrillation in the elderly population: new challenges of geriatric cardiology. Europace 21(10):1451\u20131453","journal-title":"Europace"},{"key":"537_CR50","doi-asserted-by":"publisher","first-page":"101308","DOI":"10.1016\/j.arr.2021.101308","volume":"67","author":"MC Polidori","year":"2021","unstructured":"Polidori MC, Sies H, Ferrucci L et al (2021) COVID-19 mortality as a fingerprint of biological age. Ageing Res Rev 67:101308. https:\/\/doi.org\/10.1016\/j.arr.2021.101308","journal-title":"Ageing Res Rev"},{"key":"537_CR51","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/S0140-6736(19)31786-6","volume":"394","author":"EO Hoogendijk","year":"2019","unstructured":"Hoogendijk EO, Afilalo J, Ensrud KE et al (2019) Frailty: implications for clinical practice and public health. Lancet 394:1365\u20131375","journal-title":"Lancet"},{"key":"537_CR52","first-page":"323","volume":"1","author":"AB Mitnitski","year":"2001","unstructured":"Mitnitski AB, Mogilner AJ, Rockwood K (2001) Accumulation of deficits as a proxy measure of aging. Sci World 1:323\u2013336","journal-title":"Sci World"},{"key":"537_CR53","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1111\/j.1532-5415.2004.52319.x","volume":"52","author":"X Song","year":"2004","unstructured":"Song X, Mitnitski AB, Mac Knight C et al (2004) Assessment of individual risk of death using self-report data: an artificial neural network compared with a frailty index. J Am Geriatr Soc 52:1180\u20131184","journal-title":"J Am Geriatr Soc"},{"key":"537_CR54","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1111\/j.1532-5415.2004.52521.x","volume":"52","author":"DM Jones","year":"2004","unstructured":"Jones DM, Song X, Rockwood K (2004) Operationalizing a frailty index from a standardized comprehensive geriatric assessment. J Am Geriatr Soc 52:1929\u20131933","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"537_CR55","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1161\/circheartfailure.114.001542","volume":"8","author":"SM Dunlay","year":"2015","unstructured":"Dunlay SM, Manemann SM, Chamberlain AM et al (2015) Activities of daily living and outcomes in heart failure. Circ Heart Fail 8(2):261\u2013267. https:\/\/doi.org\/10.1161\/circheartfailure.114.001542","journal-title":"Circ Heart Fail"},{"key":"537_CR56","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ejim.2018.04.018","volume":"56","author":"ER Villani","year":"2018","unstructured":"Villani ER, Tummolo AM, Palmer K et al (2018) Frailty and atrial fibrillation: a systematic review. Eur J Intern Med 56:33\u201338","journal-title":"Eur J Intern Med"},{"key":"537_CR57","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ahj.2019.01.005","volume":"211","author":"M Madhavan","year":"2019","unstructured":"Madhavan M, Holmes DN, Piccini JP, ORBIT AF Investigators et al (2019) Association of frailty and cognitive impairment with benefits of oral anticoagulation in patients with atrial fibrillation. Am Heart J 211:77\u201389","journal-title":"Am Heart J"},{"key":"537_CR58","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11739-018-1938-3","volume":"14","author":"A Gull\u00f3n","year":"2019","unstructured":"Gull\u00f3n A, Formiga F, D\u00edez-Manglano J, NONAVASC study group Vascular Risk Group of the Spanish Society of Internal Medicine et al (2019) Influence of frailty on anticoagulant prescription and clinical outcomes after 1-year follow-up in hospitalized older patients with atrial fibrillation. Intern Emerg Med 14:59\u201369","journal-title":"Intern Emerg Med"},{"key":"537_CR59","doi-asserted-by":"publisher","first-page":"jgs.16756","DOI":"10.1111\/jgs.16756","volume":"68","author":"T Mailhot","year":"2020","unstructured":"Mailhot T, McManus DD, Waring ME et al (2020) Frailty, cognitive impairment, and anticoagulation among older adults with nonvalvular atrial fibrillation. J Am Geriatr Soc 68:jgs.16756","journal-title":"J Am Geriatr Soc"},{"key":"537_CR60","first-page":"joim.13140","volume":"289","author":"GYH Lip","year":"2020","unstructured":"Lip GYH, Keshishian AV, Kang AL et al (2020) Oral anticoagulants for nonvalvular atrial fibrillation in frail elderly patients: insights from the ARISTOPHANES study. J Intern Med 289:joim.13140","journal-title":"J Intern Med"},{"issue":"2","key":"537_CR61","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cjca.2015.05.012","volume":"32","author":"MCD Lefebvre","year":"2016","unstructured":"Lefebvre MCD, St-Onge M, Glazer-Cavanagh M et al (2016) The effect of bleeding risk and frailty status on anticoagulation patterns in octogenarians with atrial fibrillation: The FRAIL-AF Study. Can J Cardiol 32(2):169\u2013176","journal-title":"Can J Cardiol"},{"key":"537_CR62","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11239-019-01937-3","volume":"49","author":"ZB Wojszel","year":"2020","unstructured":"Wojszel ZB, Kasiukievicz A (2020) Determinants of anticoagulant therapy in atrial fibrillation at discharge from a geriatric ward: cross sectional study. J Thromb Thrombolysis 49:18\u201326","journal-title":"J Thromb Thrombolysis"},{"key":"537_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101047","volume":"60","author":"A Pilotto","year":"2020","unstructured":"Pilotto A, Custodero C, Maggi S et al (2020) A multidimensional approach to frailty in older people. Ageing Res Rev 60:101047. https:\/\/doi.org\/10.1016\/j.arr.2020.101047","journal-title":"Ageing Res Rev"},{"key":"537_CR64","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.1161\/STROKEAHA.115.008225","volume":"46","author":"A Poggesi","year":"2015","unstructured":"Poggesi A, Inzitari D, Pantoni L (2015) Atrial fibrillation and cognition: epidemiological data and possible mechanisms. Stroke 46:3316\u20133321. https:\/\/doi.org\/10.1161\/STROKEAHA.115.008225","journal-title":"Stroke"},{"key":"537_CR65","doi-asserted-by":"publisher","first-page":"338","DOI":"10.7326\/0003-4819-158-5-201303050-00007","volume":"158","author":"S Kalantarian","year":"2013","unstructured":"Kalantarian S, Stern TA, Mansour M et al (2013) Cognitive impairment associated with atrial fibrillation: a meta-analysis. Ann Intern Med 158:338\u2013346. https:\/\/doi.org\/10.7326\/0003-4819-158-5-201303050-00007","journal-title":"Ann Intern Med"},{"key":"537_CR66","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2018-000984164","volume":"6","author":"A Saglietto","year":"2019","unstructured":"Saglietto A, Matta M, Gaita F et al (2019) Stroke-independent contribution of atrial fibrillation to dementia: a meta-analysis. Open Heart 6:e000984. https:\/\/doi.org\/10.1136\/openhrt-2018-000984164","journal-title":"Open Heart"},{"key":"537_CR67","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1093\/ageing\/afl164165","volume":"36","author":"H Park","year":"2007","unstructured":"Park H, Hildreth A, Thomson R et al (2007) Non-valvular atrial fibrillation and cognitive decline: a longitudinal cohort study. Age Ageing 36:157\u2013163. https:\/\/doi.org\/10.1093\/ageing\/afl164165","journal-title":"Age Ageing"},{"key":"537_CR68","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1093\/eurheartj\/ehn341","volume":"29","author":"S Knecht","year":"2008","unstructured":"Knecht S, Oelschl\u00e4ger C, Duning T et al (2008) Atrial fibrillation in stroke free patients is associated with memory impairment and hippocampal atrophy. Eur Heart J 29:2125\u20132132. https:\/\/doi.org\/10.1093\/eurheartj\/ehn341","journal-title":"Eur Heart J"},{"key":"537_CR69","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1161\/CIRCULATIONAHA.109.905091","volume":"122","author":"AL Jefferson","year":"2010","unstructured":"Jefferson AL, Himali JJ, Beiser AS et al (2010) Cardiac index is associated with brain aging: the Framingham Heart Study. Circulation 122:690\u2013697. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.905091","journal-title":"Circulation"},{"key":"537_CR70","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.amjcard.2011.06.056","volume":"108","author":"AL Jefferson","year":"2011","unstructured":"Jefferson AL, Himali JJ, Au R et al (2011) Relation of left ventricular ejection fraction to cognitive aging (from the Framingham Heart Study). Am J Cardiol 108:1346\u20131351. https:\/\/doi.org\/10.1016\/j.amjcard.2011.06.056","journal-title":"Am J Cardiol"},{"key":"537_CR71","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/gerona\/59.3.m268","volume":"59","author":"RS Tilvis","year":"2004","unstructured":"Tilvis RS, K\u00e4h\u00f6nen-V\u00e4re MH, Jolkkonen J et al (2004) Predictors of cognitive decline and mortality of aged people over a 10-year period. J Gerontol A Biol Sci Med Sci 59:268\u2013274. https:\/\/doi.org\/10.1093\/gerona\/59.3.m268","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"537_CR72","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1093\/eurheartj\/ehx579","volume":"39","author":"L Friberg","year":"2018","unstructured":"Friberg L, Rosenqvist M (2018) Less dementia with oral anticoagulation in atrial fibrillation. Eur Heart J 39:453\u2013460. https:\/\/doi.org\/10.1093\/eurheartj\/ehx579","journal-title":"Eur Heart J"},{"key":"537_CR73","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/europace\/euaa192","volume":"23","author":"D Kim","year":"2021","unstructured":"Kim D, Yang PS, Jang E et al (2021) Association of anticoagulant therapy with risk of dementia among patients with atrial fibrillation. Europace 23:184\u2013195. https:\/\/doi.org\/10.1093\/europace\/euaa192","journal-title":"Europace"},{"key":"537_CR74","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1093\/europace\/euz336","volume":"22","author":"M Gardarsdottir","year":"2020","unstructured":"Gardarsdottir M, Sigurdsson S, Aspelund T et al (2020) Improved brain perfusion after electrical cardioversion of atrial fibrillation. Europace 22:530\u2013537. https:\/\/doi.org\/10.1093\/europace\/euz336","journal-title":"Europace"},{"key":"537_CR75","doi-asserted-by":"publisher","first-page":"4483","DOI":"10.1093\/eurheartj\/ehaa726","volume":"41","author":"D Kim","year":"2020","unstructured":"Kim D, Yang PS, Sung JH et al (2020) Less dementia after catheter ablation for atrial fibrillation: a nationwide cohort study. Eur Heart J 41:4483\u20134493. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa726","journal-title":"Eur Heart J"},{"issue":"3","key":"537_CR76","first-page":"231","volume":"13","author":"MC Polidori","year":"2001","unstructured":"Polidori MC, Marvardi M, Cherubini A et al (2001) Heart disease and vascular risk factors in the cognitively impaired elderly: implications for Alzheimer\u2019s dementia. Aging (Milano) 13(3):231\u2013239","journal-title":"Aging (Milano)"},{"issue":"3","key":"537_CR77","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3233\/JAD-2012-120871","volume":"32","author":"MC Polidori","year":"2012","unstructured":"Polidori MC, Pientka L, Mecocci P (2012) A review of the major vascular risk factors related to Alzheimer\u2019s disease. J Alzheimers Dis 32(3):521\u2013530. https:\/\/doi.org\/10.3233\/JAD-2012-120871","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"537_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-2011-111034","volume":"28","author":"MC Polidori","year":"2012","unstructured":"Polidori MC, Pientka L (2012) Bridging the pathophysiology of Alzheimer\u2019s disease with vascular pathology: the feed-back, the feed-forward, and oxidative stress. J Alzheimers Dis 28(1):1\u20139. https:\/\/doi.org\/10.3233\/JAD-2011-111034","journal-title":"J Alzheimers Dis"},{"key":"537_CR79","volume-title":"Learning geriatric medicine","author":"Polidori","year":"2018","unstructured":"Polidori et al (2018) Cognitive decline. In: Roller-Wirnsberger K, Singler K, Polidori MC (eds) Learning geriatric medicine. Springer"},{"key":"537_CR80","volume-title":"comprehensive geriatric assessment","author":"MC Polidori","year":"2018","unstructured":"Polidori MC (2018) The comprehensive geriatric assessment in cognitive decline. In: Pilotto A, Martin FC (eds) comprehensive geriatric assessment. Springer"},{"key":"537_CR81","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1001\/jama.2018.8194","volume":"319","author":"V Selak","year":"2018","unstructured":"Selak V, Kerr A, Poppe K et al (2018) Annual risk of major bleeding among persons without cardiovascular disease not receiving antiplatelet therapy. JAMA 319:2507\u20132520. https:\/\/doi.org\/10.1001\/jama.2018.8194","journal-title":"JAMA"},{"key":"537_CR82","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1093\/eurheartj\/ehw454","volume":"38","author":"S Halvorsen","year":"2017","unstructured":"Halvorsen S, Storey RF, Rocca B, ESC Working Group on Thrombosis et al (2017) Management of antithrombotic therapy after bleeding in patients with coronary artery disease and\/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis. Eur Heart J 38:1455\u20131462. https:\/\/doi.org\/10.1093\/eurheartj\/ehw454","journal-title":"Eur Heart J"},{"issue":"4","key":"537_CR83","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.amjcard.2013.10.044","volume":"113","author":"W Qureshi","year":"2014","unstructured":"Qureshi W, Mittal C, Patsias I et al (2014) Restarting anticoagulation and outcomes after major gastrointestinal bleeding in atrial fibrillation. Am J Cardiol 113(4):662\u2013668. https:\/\/doi.org\/10.1016\/j.amjcard.2013.10.044","journal-title":"Am J Cardiol"},{"key":"537_CR84","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h5876","volume":"351","author":"L Staerk","year":"2015","unstructured":"Staerk L, Lip GYW, Olesen JB et al (2015) Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study. BMJ 351:h5876. https:\/\/doi.org\/10.1136\/bmj.h5876","journal-title":"BMJ"},{"key":"537_CR85","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/eurheartj\/eht483","volume":"35","author":"JP Piccini","year":"2014","unstructured":"Piccini JP, Hammill BG, Sinner MF et al (2014) Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke. Eur Heart J 35:250\u2013256","journal-title":"Eur Heart J"},{"issue":"23","key":"537_CR86","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1016\/j.jacc.2016.09.944","volume":"68","author":"A G\u00f3mez-Outes","year":"2016","unstructured":"G\u00f3mez-Outes A, Lagunar-Ru\u00edz J, Terleira-Fern\u00e1ndez A-I et al (2016) Causes of death in anticoagulated patients with atrial fibrillation. J Am Coll Cardiol 68(23):2508\u20132521","journal-title":"J Am Coll Cardiol"},{"issue":"suppl 1","key":"537_CR87","first-page":"S83","volume":"8","author":"A Pilotto","year":"2017","unstructured":"Pilotto A, Maggi S, Polidori MC et al (2017) The European study of older subjects with atrial fibrillation (EUROSAF). Aim and study design. Eur Geriatr Med 8(suppl 1):S83","journal-title":"Eur Geriatr Med"},{"key":"537_CR88","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s41999-018-0026-6","volume":"9","author":"N Veronese","year":"2018","unstructured":"Veronese N, Argusti A, Canepa E et al (2018) Evaluating the effectiveness and risks of oral anticoagulant treatments in multimorbid frail older subjects with atrial fibrillation using the multidimensional prognostic index: the EURopean study of older subjects with atrial fibrillation EUROSAF. Eur Geriatr Med 9:149\u2013154","journal-title":"Eur Geriatr Med"},{"issue":"8","key":"537_CR89","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1586\/14779072.2013.818819","volume":"11","author":"P Capranzano","year":"2013","unstructured":"Capranzano P, Miccich\u00e8 E, D\u2019Urso L et al (2013) Personalizing oral anticoagulant treatment in patients with atrial fibrillation. Expert Rev Cardiovasc Ther 11(8):959\u2013973. https:\/\/doi.org\/10.1586\/14779072.2013.818819","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"4","key":"537_CR90","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.amjcard.2016.11.006","volume":"119","author":"L Guo","year":"2017","unstructured":"Guo L, Li S, Wang P et al (2017) Comparative efficacy of clinical events prevention of five anticoagulants in patients with atrial fibrillation (a network meta-analysis). Am J Cardiol 119(4):585\u2013593. https:\/\/doi.org\/10.1016\/j.amjcard.2016.11.006","journal-title":"Am J Cardiol"},{"key":"537_CR91","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/bcp.13814","volume":"85","author":"T Mueller","year":"2019","unstructured":"Mueller T, Alvarez-Madrazo S, Robertson C et al (2019) Comparative safety and effectiveness of direct oral anticoagulants in patients with atrial fibrillation in clinical practice in Scotland. Br J Clin Pharmacol 85:422\u2013431","journal-title":"Br J Clin Pharmacol"},{"key":"537_CR92","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ejim.2017.03.012","volume":"41","author":"M Bo","year":"2017","unstructured":"Bo M, Grisoglio E, Brunetti E et al (2017) Oral anticoagulant therapy for older patients with atrial fibrillation: a review of current evidence. Eur J Intern Med 41:18\u201327","journal-title":"Eur J Intern Med"},{"issue":"21","key":"537_CR93","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1016\/j.jacc.2015.07.086","volume":"66","author":"GYH Lip","year":"2015","unstructured":"Lip GYH, Lane DA (2015) Matching the NOAC to the patient: remember the modifiable bleeding risk factors. j Am Coll Cardiol 66(21):2282\u20132284. https:\/\/doi.org\/10.1016\/j.jacc.2015.07.086","journal-title":"j Am Coll Cardiol"},{"issue":"1","key":"537_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/joim.12360","volume":"278","author":"AM Shields","year":"2015","unstructured":"Shields AM, Lip GYH (2015) Choosing the right drug to fit the patient when selecting oral anticoagulation for stroke prevention in atrial fibrillation. J Intern Med 278(1):1\u201318. https:\/\/doi.org\/10.1111\/joim.12360","journal-title":"J Intern Med"},{"issue":"12","key":"537_CR95","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1093\/eurheartj\/ehv643","volume":"38","author":"H-C Diener","year":"2017","unstructured":"Diener H-C, Aisenberg J, Ansell J et al (2017) Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1. Eur Heart J 38(12):852\u2013859. https:\/\/doi.org\/10.1093\/eurheartj\/ehv643","journal-title":"Eur Heart J"},{"issue":"12","key":"537_CR96","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1093\/eurheartj\/ehw069","volume":"38","author":"H-C Diener","year":"2017","unstructured":"Diener H-C, Aisenberg J, Ansell J et al (2017) Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2. Eur Heart J 38(12):860\u2013868. https:\/\/doi.org\/10.1093\/eurheartj\/ehw069","journal-title":"Eur Heart J"},{"issue":"4","key":"537_CR97","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/jgs.15767","volume":"67","author":"American Geriatrics Society Beers Criteria\u00ae Update Expert Panel","year":"2019","unstructured":"American Geriatrics Society Beers Criteria\u00ae Update Expert Panel (2019) American Geriatrics Society 2019 Updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc 67(4):674\u2013694. https:\/\/doi.org\/10.1111\/jgs.15767","journal-title":"J Am Geriatr Soc"},{"issue":"7","key":"537_CR98","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s40266-017-0466-6","volume":"34","author":"M Wehling","year":"2017","unstructured":"Wehling M, Collins R, Gil VM et al (2017) Appropriateness of oral anticoagulants for the long-term treatment of atrial fibrillation in older people: results of an evidence-based review and international consensus validation process (OAC-FORTA 2016). Drugs Aging 34(7):499\u2013507. https:\/\/doi.org\/10.1007\/s40266-017-0466-6","journal-title":"Drugs Aging"},{"issue":"6","key":"537_CR99","doi-asserted-by":"publisher","first-page":"e014108","DOI":"10.1161\/JAHA.119.014108","volume":"9","author":"S Sanghai","year":"2020","unstructured":"Sanghai S, Wong C, Wang Z et al (2020) Rates of potentially inappropriate dosing of direct-acting oral anticoagulants and associations with geriatric conditions among older patients with atrial fibrillation: the SAGE-AF Study. J Am Heart Assoc 9(6):e014108","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"537_CR100","doi-asserted-by":"publisher","first-page":"7633","DOI":"10.1161\/JAHA.117.007633","volume":"7","author":"BA Steinberg","year":"2018","unstructured":"Steinberg BA, Shrader P, Pieper K, Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT\u2010AF) II Investigators et al (2018) Frequency and outcomes of reduced dose non-vitamin K antagonist anticoagulants: results from ORBIT-AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II). J Am Heart Assoc 7(4):7633","journal-title":"J Am Heart Assoc"},{"key":"537_CR101","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/jcpt.12473","volume":"42","author":"M Viprey","year":"2017","unstructured":"Viprey M, Jeannin R, Piriou V et al (2017) Prevalence of drug-related problems associated with direct oral anticoagulants in hospitalized patients: a multicenter, cross-sectional study. J Clin Pharm Ther 42:58\u201363","journal-title":"J Clin Pharm Ther"},{"key":"537_CR102","doi-asserted-by":"publisher","DOI":"10.1007\/s41999-021-00452-0","author":"T Erdogan","year":"2021","unstructured":"Erdogan T, Erdogan O, Ozturk S et al (2021) Non-vitamin K antagonist oral anticoagulant use at doses inappropriately lower than recommended in outpatient older adults: a real-life data. Eur Geriatr Med. https:\/\/doi.org\/10.1007\/s41999-021-00452-0","journal-title":"Eur Geriatr Med"},{"key":"537_CR103","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcvp\/pvaa103","author":"M Bo","year":"2020","unstructured":"Bo M, Corsini A, Brunetti E et al (2020) Off-label use of reduced dose direct oral factor Xa-inhibitors in subjects with atrial fibrillation: a review of clinical evidence. Eur Heart J Cardiovasc Pharmacother. https:\/\/doi.org\/10.1093\/ehjcvp\/pvaa103","journal-title":"Eur Heart J Cardiovasc Pharmacother."},{"issue":"19","key":"537_CR104","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1093\/eurheartj\/ehy802","volume":"40","author":"KL Wang","year":"2019","unstructured":"Wang KL, Lopes RD, Patel MR et al (2019) Efficacy and safety of reduced-dose non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a meta-analysis of randomized controlled trials. Eur Heart J 40(19):1492\u20131500","journal-title":"Eur Heart J"},{"key":"537_CR105","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1056\/NEJMoa2012883","volume":"383","author":"K Okumura","year":"2020","unstructured":"Okumura K, Akao M, Yoshida T et al (2020) Low-dose edoxaban in very elderly patients with atrial fibrillation. N Engl J Med 383:1735\u20131745","journal-title":"N Engl J Med"},{"issue":"5","key":"537_CR106","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1093\/europace\/eut333","volume":"16","author":"S Sj\u00e4lander","year":"2014","unstructured":"Sj\u00e4lander S, Sj\u00e4lander A, Svensson PJ et al (2014) Atrial fibrillation patients do not benefit from acetylsalicylic acid. Europace 16(5):631\u2013638","journal-title":"Europace"},{"issue":"9586","key":"537_CR107","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","volume":"370","author":"J Mant","year":"2007","unstructured":"Mant J, Hobbs FD, Fletcher K, BAFTA Investigators et al (2007) Midland Research Practices Network (MidReC). Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 370(9586):493\u2013503","journal-title":"Lancet"},{"issue":"8","key":"537_CR108","doi-asserted-by":"publisher","first-page":"e008150","DOI":"10.1161\/JAHA.117.008150","volume":"7","author":"YH Chan","year":"2018","unstructured":"Chan YH, See LC, Tu HT et al (2018) Efficacy and safety of apixaban, dabigatran, rivaroxaban, and warfarin in Asians with nonvalvular atrial fibrillation. J Am Heart Assoc 7(8):e008150","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"537_CR109","doi-asserted-by":"publisher","first-page":"e005657","DOI":"10.1161\/JAHA.117.005657","volume":"6","author":"G Patti","year":"2017","unstructured":"Patti G, Lucerna M, Pecen L et al (2017) Thromboembolic risk, bleeding outcomes and effect of different antithrombotic strategies in very elderly patients with atrial fibrillation: a sub-analysis from the PREFER in AF (PREvention oF\u00a0Thromboembolic Events-European\u00a0Registry in\u00a0Atrial\u00a0Fibrillation). J Am Heart Assoc 6(7):e005657","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"537_CR110","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s40119-013-0019-y","volume":"2","author":"KH Ng","year":"2013","unstructured":"Ng KH, Hart RG, Eikelboom JW (2013) Anticoagulation in patients aged \u226575 years with atrial fibrillation: role of novel oral anticoagulants. Cardiol Ther 2(2):135\u2013149","journal-title":"Cardiol Ther"},{"issue":"1","key":"537_CR111","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/ageing\/afv156","volume":"45","author":"KH Ng","year":"2016","unstructured":"Ng KH, Shestakovska O, Connolly SJ et al (2016) Efficacy and safety of apixaban compared with aspirin in the elderly: a subgroup analysis from the AVERROES trial. Age Ageing 45(1):77\u201383","journal-title":"Age Ageing"},{"issue":"9526","key":"537_CR112","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","volume":"367","author":"S Connolly","year":"2006","unstructured":"ACTIVE Writing Group of the ACTIVE Investigators, Connolly S, Pogue J et al (2006) Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomized controlled trial. Lancet 367(9526):1903\u20131912","journal-title":"Lancet"},{"issue":"9","key":"537_CR113","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"V Aboyans","year":"2018","unstructured":"Aboyans V, Ricco JB, Bartelink MEL, ESC Scientific Document Group et al (2018) 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Endorsed by: the European Stroke Organization (ESO) The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J 39(9):763\u2013816","journal-title":"Eur Heart J"},{"issue":"3","key":"537_CR114","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s41999-020-00297-z","volume":"11","author":"G Bahat","year":"2020","unstructured":"Bahat G, Ilhan B, Erdogan T et al (2020) Turkish Inappropriate Medication use in the Elderly (TIME) criteria to improve prescribing in older adults: TIME-to-STOP\/TIME-to-START. Eur Geriatr Med 11(3):491\u2013498","journal-title":"Eur Geriatr Med"},{"issue":"7","key":"537_CR115","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s40266-018-0554-2","volume":"35","author":"D Mangin","year":"2018","unstructured":"Mangin D, Bahat G, Golomb BA et al (2018) International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): position statement and 10 recommendations for action. Drugs Aging 35(7):575\u2013587. https:\/\/doi.org\/10.1007\/s40266-018-0554-2","journal-title":"Drugs Aging"},{"key":"537_CR116","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejim.2020.11.014","volume":"85","author":"MG Abrignani","year":"2021","unstructured":"Abrignani MG, Gatta L, Gabrielli D et al (2021) Gastroprotection in patients on antiplatelet and\/or anticoagulant therapy: a position paper of National Association of Hospital Cardiologists (ANMCO) and the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO). Eur J Intern Med 85:1\u201313. https:\/\/doi.org\/10.1016\/j.ejim.2020.11.014","journal-title":"Eur J Intern Med"},{"issue":"21","key":"537_CR117","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1001\/jama.2018.17242","volume":"320","author":"WA Ray","year":"2018","unstructured":"Ray WA, Chung CP, Murray KT et al (2018) Association of oral anticoagulants and proton pump inhibitor cotherapy with hospitalization for upper gastrointestinal tract bleeding. JAMA 320(21):2221\u20132230","journal-title":"JAMA"},{"issue":"13","key":"537_CR118","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1001\/jama.2017.13883","volume":"318","author":"SH Chang","year":"2017","unstructured":"Chang SH, Chou IJ, Yeh YH et al (2017) Association Between use of non-vitamin k oral anticoagulants with and without concurrent medications and risk of major bleeding in nonvalvular atrial fibrillation. JAMA 318(13):1250\u20131259. https:\/\/doi.org\/10.1001\/jama.2017.13883","journal-title":"JAMA"},{"issue":"1","key":"537_CR119","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1161\/CIRCRESAHA.120.316340","volume":"127","author":"J Kornej","year":"2020","unstructured":"Kornej J, B\u00f6rschel CS, Benjamin EJ et al (2020) Epidemiology of atrial fibrillation in the 21st century: novel methods and new insights. Circ Res 127(1):4\u201320. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.316340","journal-title":"Circ Res"}],"container-title":["European Geriatric Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41999-021-00537-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s41999-021-00537-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41999-021-00537-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T18:11:59Z","timestamp":1675879919000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s41999-021-00537-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,2]]},"references-count":119,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["537"],"URL":"https:\/\/doi.org\/10.1007\/s41999-021-00537-w","relation":{},"ISSN":["1878-7657"],"issn-type":[{"value":"1878-7657","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,2]]},"assertion":[{"value":"29 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Nothing to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}